Hansa Biopharma has encouraging early clinical results showing its drug imlifidase, used as a pretreatment, enabled Duchenne muscular dystrophy patients to receive the gene therapy Elevidys. Sarepta is searching for ways to mitigate excessive immune responses to Elevidys that can lead to serious and potentially fatal liver injury. The post Sarepta’s Future in Gene Therapy…
Today’s AI is not truly agentic because it’s not truly independent of you. The current crop of agents can’t set complex goals, or properly verify outputs. You have to spend a lot of effort on prompting, verifying, and system integrating. That just means the smarter you are, the smarter the AI is. It’s really amplified…
The HHS Secretary contends that federal policy financially rewarded hospitals for reporting staff vaccination rates
Premiums will rise in 2026 for most of the 22 million people who receive premium tax credits, experts say
This data note examines the role that immigrants play in the rural workforce, particularly in industries disproportionately filled by immigrants, including health care, agriculture, construction, and service.
Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…
Until a new CEO is identified, three principal executives are jointly managing CEO responsibilities at the company
HTI-4 rule adds a new certification criterion enabling prescriber access to prescription benefit information at the point of care
That is the title of my most recent paper published in Clinical Lung Cancer with co-authors Mark Danese, Melissa Laurie, Beata Korytowsky, Shane Jordan, Debbie Ryan and Sukhmani K. Padda. The study abstract is below. ObjectiveThis study examined brain metastases among patients with metastatic non-small cell lung cancer (mNSCLC), characterizing prevalence, use of brain imaging,…
Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations. The post The Future of Glucose Monitoring: Why Blood-Based Measurements Matter appeared first on MedCity News.